ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - January 1920

Decade

Year

Issue

November 2022, Vol 158, No. 11, Pages 1235-1333

Editorial

Resurgence of Syphilis in the US—USPSTF Reaffirms Screening Guidelines

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1241-1243. doi:10.1001/jamadermatol.2022.3499

Difficult Dermatophytosis

Abstract Full Text
JAMA Dermatol. 2022;158(11):1243-1244. doi:10.1001/jamadermatol.2022.3736
Original Investigation

Assessment of the Genetic Spectrum of Uncombable Hair Syndrome in a Cohort of 107 Individuals

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1245-1253. doi:10.1001/jamadermatol.2022.2319

This cohort study aims to elucidate the genetic spectrum of uncombable hair syndrome among 107 included patients.

Association of Risk of Incident Venous Thromboembolism With Atopic Dermatitis and Treatment With Janus Kinase Inhibitors: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1254-1261. doi:10.1001/jamadermatol.2022.3516

This systematic review and meta-analysis examines the risk of incident venous thromboembolism among patients with atopic dermatitis who were receiving treatment with Janus kinase inhibitors.

Association Between Inflammatory Bowel Disease and Both Psoriasis and Psoriatic Arthritis: A Bidirectional 2-Sample Mendelian Randomization Study

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1262-1268. doi:10.1001/jamadermatol.2022.3682

This mendelian randomization study investigates the associations between inflammatory bowel disease, particularly Crohn disease and ulcerative colitis, and psoriasis and psoriatic arthritis.

Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1269-1278. doi:10.1001/jamadermatol.2022.3745

This randomized clinical trial compares cure rates, treatment durations, safety profiles, and relapse rates of itraconazole, 100, 200, and 400 mg/d, for the treatment of tinea corporis/cruris in adult patients.

Reevaluating Corticosteroid Classification Models in Patient Patch Testing

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1279-1286. doi:10.1001/jamadermatol.2022.3774

This qualitative study uses Mayo Clinic patient data to determine copositivity patterns between corticosteroids and to evaluate against previous corticosteroid classification models.

Differences in Skin Cancer Rates by Transplanted Organ Type and Patient Age After Organ Transplant in White Patients

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1287-1292. doi:10.1001/jamadermatol.2022.3878

This cohort study compares the rates of development of a second or third skin cancer among transplant recipients and whether those rates vary by type of organ transplant received and age at the time of transplant.

Brief Report

Clinical Presentation and Outcome Differences Between Black Patients and Patients of Other Races and Ethnicities With Mycosis Fungoides and Sézary Syndrome

Abstract Full Text
JAMA Dermatol. 2022;158(11):1293-1299. doi:10.1001/jamadermatol.2022.3601

This cohort study assesses racial differences in presentation and outcome and identifies drivers for racial disparities among patients with mycosis fungoides and Sézary syndrome.

Comparison of Work Relative Value Units for Outpatient Pediatric and Adult Dermatology Encounters

Abstract Full Text
JAMA Dermatol. 2022;158(11):1300-1303. doi:10.1001/jamadermatol.2022.3609

This cross-sectional study compares work relative value units generated for pediatric vs adult outpatient dermatology encounters.

Review

Credibility and Generalization of the Minimally Important Difference Concept in Dermatology: A Scoping Review

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(11):1304-1314. doi:10.1001/jamadermatol.2022.3511

This scoping review evaluates the credibility and generalization of minimally important differences for patient-reported outcome measures in skin disorders.

Images in Dermatology

Netherton Syndrome

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(11):1315. doi:10.1001/jamadermatol.2022.3796

This case report describes dry skin with marked redness of the face and hands as well as trichorrhexis invaginata.

Peutz-Jeghers Syndrome

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(11):1316. doi:10.1001/jamadermatol.2022.3979

This case report describes multiple dark-brown 1- to 2-mm hyperpigmented macules on the lips, nose, and conjunctivae.

JAMA Dermatology Clinicopathological Challenge

Generalized Nodules in an Older Adult Man

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(11):1317-1318. doi:10.1001/jamadermatol.2022.4297

A man in his 60s presented with an 8-month history of pruritic papulonodular lesions on his extremities and trunk, with no significant improvement with steroids and antihistamines. What is your diagnosis?

Numerous Angiomatous Lesions in an Infant

Abstract Full Text
has active quiz
JAMA Dermatol. 2022;158(11):1319-1320. doi:10.1001/jamadermatol.2022.4378

A 3-month-old infant presented with bright red macules, papules, and plaques that appeared at birth and grew in size and number. What is your diagnosis?

Research Letter

Incidence of Dermatomyositis in a Nationwide Cohort Study of US Veterans

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1321-1323. doi:10.1001/jamadermatol.2022.3112

This cohort study evaluates the incidence of dermatomyositis and its trend over time in the US Department of Veterans Affairs health care system.

Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1323-1325. doi:10.1001/jamadermatol.2022.3180

This quality improvement study assesses the prevalence of contact allergens in personal care products classified as clean or natural among 3 national retailers in the US.

Optimized User Experience, Efficiency, and Resource Use in Online Self-Management of Atopic Dermatitis

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1325-1327. doi:10.1001/jamadermatol.2022.3434

This quality improvement study describes the revision of an internet-delivered, self-guided psychological treatment for atopic dermatitis.

Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab

Abstract Full Text
open access has active quiz
JAMA Dermatol. 2022;158(11):1327-1330. doi:10.1001/jamadermatol.2022.3488

This case series describes the outcomes of COVID-19 and SARS-CoV-2 vaccination in patients with atopic dermatitis who have been treated with tralokinumab.

Observation

Treatment of Warts With Needle-Free Injection of Fluorouracil

Abstract Full Text
JAMA Dermatol. 2022;158(11):1330-1331. doi:10.1001/jamadermatol.2022.3318

This case report describes 2 men in their 20s who presented with warts that were treated with a needle-free injection of fluorouracil.

Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus

Abstract Full Text
JAMA Dermatol. 2022;158(11):1331-1332. doi:10.1001/jamadermatol.2022.2793

This case report describes a 17-year-old male patient with frog spawn–like vesicles around the urethra.

Comment & Response

Melanoma Screening

Abstract Full Text
JAMA Dermatol. 2022;158(11):1332-1333. doi:10.1001/jamadermatol.2022.3907

Melanoma Screening—Reply

Abstract Full Text
JAMA Dermatol. 2022;158(11):1333. doi:10.1001/jamadermatol.2022.3906
Correction

Updated Link and Survey Tool Added to Supplement

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1333. doi:10.1001/jamadermatol.2022.4185
JAMA Dermatology Masthead

JAMA Dermatology

Abstract Full Text
free access
JAMA Dermatol. 2022;158(11):1235. doi:10.1001/jamadermatol.2021.4234
×